Immuno-oncology Archives - Oncology Central Oncology Central

i
i

2 Jun 2019 Breast
ASCO19: ribociclib combined with endocrine therapy increases survival in breast cancer patients
1 Jun 2019 Lung
ASCO19: 5-year data shows that pembrolizumab increases survival rates for certain NSCLC patients
2 May 2019 Journal Articles
Talimogene laherparepvec: review of its mechanism of action and clinical efficacy and safety
24 Apr 2019 Gastrointestinal
At the crossroads: the intersection of the gut microbiome and immuno-oncology
24 Apr 2019 Renal
Keytruda® in combination with Inlyta® receives US FDA approval for renal cell carcinoma
15 Apr 2019 Lung
Maintenance immunotherapy fails to improve survival in extensive-stage SCLC
15 Apr 2019 Colorectal
Organoid study sheds light on how colorectal cancer cells may avoid immunotherapy
10 Apr 2019 Lung
Real-life study suggests shorter overall survival with immunotherapy in elderly NSCLC patients
10 Apr 2019 Lung
KEYNOTE trials demonstrate improved survival with pembrolizumab in elderly patients
5 Apr 2019 Lung
Pembrolizumab for small-cell lung cancer: an interview with Hyun Cheol Chung
5 Apr 2019 Opinion
Direct drug delivery and electroporation for internal tumors: a new platform developed by OncoSec
2 Apr 2019 News
AACR19 day 2 update: pembrolizumab, UNITY-NHL trial results and more